ChemoCentryx, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 33 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-10-20: Reporting owner Jain Rita; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-10-20: Reporting owner Edwards Thomas A.; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-10-20: Reporting owner Parker Geoffrey M.; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-10-20: Reporting owner KANAYA SUSAN M; Form 4; Security Restricted Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-10-20 | Jain Rita Director, Officer (EVP, Chief Medical Officer) | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,600 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Edwards Thomas A. Director | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,723 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Parker Geoffrey M. Director | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,723 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | KANAYA SUSAN M Director, Officer (See Remarks) | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,968 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Tyree James L Director | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,723 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | FECZKO JOSEPH M Director | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,723 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −239,934 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −61,467 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Wheadon David E. Director | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,274 0 owned after | no price filed | 2022-10-24 | |
| 2022-10-20 | Butt Tausif Officer (EVP, Chief Operating Officer) | 4 | Restricted Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −41,400 0 owned after | no price filed | 2022-10-24 | |
| 2022-05-26 | Wheadon David E. Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,274 22,274 owned after | no price filed | 2022-05-31 | |
| 2022-05-26 | Tyree James L Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,723 15,723 owned after | no price filed | 2022-05-31 | |
| 2022-05-26 | Parker Geoffrey M. Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,723 15,723 owned after | no price filed | 2022-05-31 | |
| 2022-05-26 | FECZKO JOSEPH M Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,723 15,723 owned after | no price filed | 2022-05-31 | |
| 2022-05-20 | Tyree James L Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,726 0 owned after | no price filed | 2022-05-24 | |
| 2022-05-20 | Parker Geoffrey M. Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,726 0 owned after | no price filed | 2022-05-24 | |
| 2022-05-20 | MCKINNELL HENRY A Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,726 0 owned after | no price filed | 2022-05-24 | |
| 2022-05-20 | Jain Rita Director, Officer (EVP, Chief Medical Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,726 0 owned after | no price filed | 2022-05-24 | |
| 2022-03-27 | Jain Rita Director, Officer (EVP, Chief Medical Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,251 0 owned after | no price filed | 2022-03-29 | |
| 2022-02-22 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +152,700 152,700 owned after | no price filed | 2022-02-25 | |
| 2022-02-22 | Butt Tausif Officer (EVP, Chief Operating Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,400 41,400 owned after | no price filed | 2022-02-24 | |
| 2022-02-22 | KANAYA SUSAN M Director, Officer (EVP, CFO and Sec.) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +59,700 59,700 owned after | no price filed | 2022-02-24 | |
| 2022-02-22 | Jain Rita Director, Officer (EVP, Chief Medical Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,600 11,600 owned after | no price filed | 2022-02-24 | |
| 2022-02-22 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,700 40,700 owned after | no price filed | 2022-02-24 | |
| 2022-01-01 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,334 0 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −34,567 34,567 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,333 52,667 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | KANAYA SUSAN M Director, Officer (EVP, CFO and Sec.) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | KANAYA SUSAN M Director, Officer (EVP, CFO and Sec.) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,333 10,334 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | KANAYA SUSAN M Director, Officer (EVP, CFO and Sec.) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,466 20,934 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,667 0 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,767 7,767 owned after | no price filed | 2022-01-04 | |
| 2022-01-01 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,500 13,000 owned after | no price filed | 2022-01-04 |